Our science team seems to be satisfied to have the third party input in advancing our molecules. Same as the sister company,,,only this one seems to be a leg up in one way.There is nothing coming from any of our professional scientists in regards to our focus around epigenetics. Its like they dont exist. And maybe they dont in a way when it comes down to it. Its a good gig perhaps in some fashion. It also must be an embarrassment to these same highly educated people or at least it should be. For DMcC,,,you cant embarrass him,,,we all know that,,,,a talking head. Any CEO with his track record would have been ousted by the major insiders years ago. This low share price is orchestrated and we should know where that leads. Little changes year after year after year here. And Oncology was said to be a fast moving sector in biotech trials,,,,,,as if the team actually knew something about this sector,,,,,without these BPs we would be still globe trotting sending out the good word. Yet here we are 9 years later still surrounded by mystery!